Jimi Olaghere Sugarloaf Capital

Jimi Olaghere is a CasGevy recipient who has developed a keen interest in the advancements of Cell and Gene therapies, since transformative participation in the groundbreaking clinical trial. He is passionate about the positive impact these therapies can have on patients in need and has become a staunch advocate for increased accessibility of gene therapies for SCD patients worldwide.